Jeffrey H. Murray

Array ( [id] => 6351570 [patent_doc_number] => 20100331296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/682508 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40988 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331296.pdf [firstpage_image] =>[orig_patent_app_number] => 12682508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8784754 [patent_doc_number] => 08431596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => '[1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use' [patent_app_type] => utility [patent_app_number] => 12/679871 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59714 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12679871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4553291 [patent_doc_number] => 07820662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => '6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/244947 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137331 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820662.pdf [firstpage_image] =>[orig_patent_app_number] => 12244947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564604 [patent_doc_number] => 20090137457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Pyrimidinedione derivatives' [patent_app_type] => utility [patent_app_number] => 12/286903 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9107 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137457.pdf [firstpage_image] =>[orig_patent_app_number] => 12286903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398469 [patent_doc_number] => 08268849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Multifunctional Antioxidants and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/237936 [patent_app_country] => US [patent_app_date] => 2008-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 14965 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12237936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402356 [patent_doc_number] => 20100305143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'PYRROLOPYRIMIDINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/677919 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10964 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305143.pdf [firstpage_image] =>[orig_patent_app_number] => 12677919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361677 [patent_doc_number] => 20090036471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Triazolopyrimidine Derivatives As Glycogen Synthase Kinase 3 Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/211361 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28407 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036471.pdf [firstpage_image] =>[orig_patent_app_number] => 12211361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6350802 [patent_doc_number] => 20100249151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'IMIDAZO 1, 2-A PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS DIABETES' [patent_app_type] => utility [patent_app_number] => 12/682316 [patent_app_country] => US [patent_app_date] => 2008-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12962 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249151.pdf [firstpage_image] =>[orig_patent_app_number] => 12682316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870787 [patent_doc_number] => 08466164 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => '4-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/678021 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 19 [patent_no_of_words] => 13583 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12678021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272260 [patent_doc_number] => 20090076036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED RISPERIDONE' [patent_app_type] => utility [patent_app_number] => 12/208684 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3270 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076036.pdf [firstpage_image] =>[orig_patent_app_number] => 12208684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4465149 [patent_doc_number] => 07935815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Imidazoyl pyridine compounds and salts thereof' [patent_app_type] => utility [patent_app_number] => 12/200731 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 163938 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935815.pdf [firstpage_image] =>[orig_patent_app_number] => 12200731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324310 [patent_doc_number] => 20090062300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DEUTERIUM-ENRICHED PRAZOSIN' [patent_app_type] => utility [patent_app_number] => 12/198042 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4062 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062300.pdf [firstpage_image] =>[orig_patent_app_number] => 12198042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410743 [patent_doc_number] => 20090124642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Crystalline forms of Erlotinib HCI and formulations thereof' [patent_app_type] => utility [patent_app_number] => 12/229682 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6868 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124642.pdf [firstpage_image] =>[orig_patent_app_number] => 12229682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324322 [patent_doc_number] => 20090062312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DEUTERIUM-ENRICHED INDIPLON' [patent_app_type] => utility [patent_app_number] => 12/196003 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3428 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062312.pdf [firstpage_image] =>[orig_patent_app_number] => 12196003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324320 [patent_doc_number] => 20090062310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DEUTERIUM-ENRICHED VORICONAZOLE' [patent_app_type] => utility [patent_app_number] => 12/195857 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3718 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062310.pdf [firstpage_image] =>[orig_patent_app_number] => 12195857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337928 [patent_doc_number] => 20090054392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'NAPHTHYLPYRIMIDINE, NAPHTHYLPYRAZINE AND NAPHTHYLPYRIDAZINE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/194235 [patent_app_country] => US [patent_app_date] => 2008-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70676 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054392.pdf [firstpage_image] =>[orig_patent_app_number] => 12194235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324318 [patent_doc_number] => 20090062308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'METHODS OF USING SODIUM CHANNEL BLOCKERS' [patent_app_type] => utility [patent_app_number] => 12/190022 [patent_app_country] => US [patent_app_date] => 2008-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 34154 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062308.pdf [firstpage_image] =>[orig_patent_app_number] => 12190022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536390 [patent_doc_number] => 20100204196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => '2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer' [patent_app_type] => utility [patent_app_number] => 12/671960 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 178161 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204196.pdf [firstpage_image] =>[orig_patent_app_number] => 12671960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136552 [patent_doc_number] => 20110009392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'GAMMA SECRETASE MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/671806 [patent_app_country] => US [patent_app_date] => 2008-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69787 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009392.pdf [firstpage_image] =>[orig_patent_app_number] => 12671806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484243 [patent_doc_number] => 20110250138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'SINGLE-STRANDED AND DOUBLE-STRANDED OLIGONUCLEOTIDES COMPRISING A METAL-CHELATING LIGAND' [patent_app_type] => utility [patent_app_number] => 12/671677 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 29557 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250138.pdf [firstpage_image] =>[orig_patent_app_number] => 12671677 [rel_patent_id] =>[rel_patent_doc_number] =>)